Advances in Gerontology

, Volume 8, Issue 1, pp 71–78 | Cite as

Attitudes towards Aging Prevention: Results of a Focus-Group Study

  • A. A. Smol’kin
  • P. A. Zhigareva
  • E. A. Makarova
  • A. A. Kiryukhina
  • E. A. Milova
  • D. A. Khaltourina


Emerging life-extension technologies and generally used therapies aimed at preventing agingrelated pathological processes have significant potential to alleviate the burden of disease in an aging world. However, promoting these technologies requires research of public opinion with the use of marketing techniques. We studied social attitudes toward life-extension technologies and use of geroprotective medicines by conducting three focus groups. The total sample included 18 people with university degrees 25–70 years of age who were living in Moscow (Russia). The tested statements were obtained in advance by surveying 30 experts in gerontology. The focus group participants were most in agreement with the statement that “aging prevention will help to maintain health and increase the active period of life.” Despite the doubts of experts, the idea that aging is a disease convinces a considerable share of the informants when the scientific evidence of the connection between aging processes and aging-related health damage is provided. Introducing new agendas into the discussion (pensions, overpopulation, etc.) turned out to be counterproductive due to new counterarguments emerging in the group discussions. The idea of radical life extension (200 years and more) was perceived skeptically. Some skepticism was attributed to mistrust and disappointment in the modern healthcare system in general. Gene therapies were perceived with caution. The word “geroprotector” is not well known even to the educated general public.


focus groups longevity technologies geroprotectors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Most Russians want to live until 80 years old. Scholar
  2. 2.
    Gil’, A.Yu., Milova, E.A., and Khalturina, D.A., Profilaktika stareniya dlya vsekh (Popular Handbook of Aging Prevention), Anisimov, V.N., Ed., Moscow: Uchitel’, 2015.Google Scholar
  3. 3.
    How long Russian want to live, Levada Center, February 6, 2012. Scholar
  4. 4.
    Anisimov, V.N., Semenchenko, A.V., and Yashin, A.I., Insulin and longevity: antidiabetic biguanides as geroprotectors, Biogerontology, 2003, vol. 4, no. 5, pp. 297–307.CrossRefPubMedGoogle Scholar
  5. 5.
    Calnan, M., Montaner, D., and Horne, R., How acceptable are innovative health-care technologies? A survey of public beliefs and attitudes in England and Wales, Soc. Sci. Med., 2005, vol. 60, no. 9, pp. 1937–1948.CrossRefPubMedGoogle Scholar
  6. 6.
    Donnan, P.T., MacDonald, T.M., and Morris, A.D., Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study, Diabetic Med., 2002, vol. 19, no. 4, pp. 279–284.CrossRefPubMedGoogle Scholar
  7. 7.
    Donner, Y., Fortney, K., Calimport, S.R.G., et al., Great desire for extended life and health amongst the American public, Front. Genet., 2015, vol. 6, p. 353.PubMedGoogle Scholar
  8. 8.
    Lang, F.R., Baltes, P.B., and Wagner, G.G., Desired lifetime and end-of-life desires across adulthood from 20 to 90: a dual-source information model, J. Gerontol., Ser. B, 2007, vol. 62, no. 5, pp. P268–P276.CrossRefGoogle Scholar
  9. 9.
    Partridge, B., Lucke, J., Bartlett, H., and Hall, W., Ethical, social, and personal implications of extended human lifespan identified by members of the public, Rejuvenat. Res., 2009, vol. 12, no. 5, pp. 351–357.CrossRefGoogle Scholar
  10. 10.
    Partridge, B., Lucke, J., Bartlett, H., and Hall, W., Public attitudes towards human life extension by intervening in ageing, J. Aging Stud., 2011, vol. 25, no. 2, pp. 73–83.CrossRefGoogle Scholar
  11. 11.
    Perry, D., Someone’s knocking on the laboratory door, Rejuvenat. Res., 2004, vol. 7, no. 1, pp. 49–52.CrossRefGoogle Scholar
  12. 12.
    Living to 120 and beyond: Americans’ views on aging, medical advances and radical life extension, Pew Research Center, 2013. http://www.pewforum. org/2013/08/06/living-to-120-and-beyond-americans-views-on-aging-medicaladvances-and-radical-lifeextension/.Google Scholar
  13. 13.
    Settersten, R.A., Flatt, M.A., and Ponsaran, R., From the lab to the front line: how individual biogerontologists navigate their contested field, J. Aging Stud., 2008, vol. 22, no. 4, pp. 304–312.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Shepherd, R., Barnett, J., Cooper, H., et al., Towards an understanding of British public attitudes concerning human cloning, Soc. Sci. Med., 2007, vol. 65, no. 2, pp. 377–392.CrossRefPubMedGoogle Scholar
  15. 15.
    CARP Radical Life Extension Poll Report September 6, 2013. Scholar

Copyright information

© Pleiades Publishing, Ltd. 2018

Authors and Affiliations

  • A. A. Smol’kin
    • 1
    • 2
  • P. A. Zhigareva
    • 1
  • E. A. Makarova
    • 1
  • A. A. Kiryukhina
    • 1
  • E. A. Milova
    • 3
  • D. A. Khaltourina
    • 4
    • 5
  1. 1.Russian Presidential Academy of the National Economy and Public AdministrationMoscowRussia
  2. 2.Moscow School of Social and Economic SciencesMoscowRussia
  3. 3.Regional NGO Optimum HealthMoscowRussia
  4. 4.Federal State Institution National Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian FederationMoscowRussia
  5. 5.Regional Russian NGO Council for Public Health and DemographyMoscowRussia

Personalised recommendations